Back to Journals » OncoTargets and Therapy » Volume 4

Review

Eribulin mesylate as a microtubule inhibitor for treatment of patients with metastatic breast cancer

         
Total article views   Abstract views HTML views PDF downloads Totals
10,365 Dovepress* 7,877 536+ 1,602 8,413
PubMed Central* 13 1,939 584 1,952
Totals 7,890 2,475 2,186 10,365
*Since 14 November 2011
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar